Overexpression of vasopressin (V3) and corticotrophin‐releasing hormone receptor genes in corticotroph tumours
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The molecular mechanisms underlying ACTH‐secreting tumour formation remain unknown. Transmembrane signalling pathways play an important role in several endocrine disorders including pituitary tumours. To investigate the role of the pituitary vasopressin (V3) receptor (R) in ACTH‐secreting tumours we have qualitatively and quantitatively analysed its mRNA. DESIGN: RT–PCR, denaturing gradient gel electrophoresis and S1 nuclease protection experiments were used to analyse V3 mRNA structure in ACTH‐secreting tumours. We also developed a competitive RT–PCR system to compare the levels of expression of POMC, V3 and CRH‐R genes. This system used as competitor a single mutant template (termed multi‐mutant) containing primers for the three genes flanking an unrelated core sequence allowing multiple quantifications from the same cDNA preparations. We analysed 12 normal pituitaries, 15 corticotroph pituitary adenomas and 6 ACTH‐secreting bronchial carcinoids. RESULTS: The V3 mRNA structure and sequence were found to be identical in normal and tumoural pituitary indicating that the tumoural Vs mRNA codes for a normal receptor. POMC RT–PCR signals in the pituitary tumour group were approximately 7‐fold higher than in the normal pituitary group. Similarly, V3 and CRH‐R signal were increased in pituitary tumors (mean ± SEM: 5.87 × 10−6 ± 1.73 × 10−6, and 2.33 × 10−4 ± 1.4 × 10−4, respectively), when compared to normal pituitaries (1.19 × 10−7 ± 2.39 × 10−8, and 1.7 × 10−6 ± 4.65 × 10−7, respectively) suggesting that these two genes are expressed at very high levels in corticotroph tumours. When expressed relative to the corresponding POMC signals, increases in V3 and CRH‐R signals reached 49‐fold and 137‐fold, respectively, in pituitary tumours. In ACTH‐secreting bronchial carcinoids V3 gene expression level was also higher than in normal pituitary, whereas CRH‐R signals were detected in only 4 of the 6 tumours with wide variations. CONCLUSION: Our results show that both vasopressin and CRH receptor genes are overexpressed in ACTH‐secreting pituitary tumours. They suggest that overexpression of G protein‐coupled receptors may be an additional mechanism through which membrane receptors may play a role in human tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
Gillies, G. E., Linton, E. A., & Lowry, P. J. (1982) · Nature · doi:10.1038/299355a0 · Cited by 965 · cited 1×
“This might be important, since CRH is the major positive regulator of POMC gene expression and since these two receptors, although coupled to different signalling pathways, act synergistically to stimulate POMC expression (Gillies et al., 1982).”
BackgroundCloning and characterization of the human V3 pituitary vasopressin receptor
de Keyzer, Y., Auzan, C., Lenne, F., Beldjord, C., Thibonnier, M., Bertagna, X., & Clauser, E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01268-7 · Cited by 209
Self-citation
Cited by
The Treatment of Cushing's Disease
Pivonello, R., De Leo, M., Cozzolino, A., & Colao, A. (2015) · Endocrine Reviews · doi:10.1210/er.2013-1048 · Cited by 465
Hauger, R., Risbrough, V., Brauns, O., & Dautzenberg, F. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706777950684 · Cited by 343
Gal, C. S.-L., Wagnon, J., Simiand, J., Griebel, G., Lacour, C., Guillon, G., Barberis, C., Brossard, G., Soubrié, P., Nisato, D., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.1122 · Cited by 211
Folny, V., Raufaste, D., Lukovic, L., Pouzet, B., Rochard, P., Pascal, M., & Serradeil-Le Gal, C. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00148.2003 · Cited by 61
Gal, C. S.-L., Raufaste, D., Derick, S., Blankenstein, J., Allen, J., Pouzet, B., Pascal, M., Wagnon, J., & Ventura, M. A. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00062.2007 · Cited by 35
Metadata
- Authors
- De Keyzer, Y., René, P., Beldjord, C., Lenne, F., & Bertagna, X.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1998-10
- Volume
- 49
- Issue
- 4
- Pages
- 475-482
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2065437604
- Cited by
- 87
- References
- 2
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Overexpression of vasopressin (V3) and corticotrophin‐releasing hormone receptor genes in corticotroph tumours. https://app.cochat.ai/papers/10.1046/j.1365-2265.1998.00560.x
- The paper
- De Keyzer, Y., René, P., Beldjord, C., Lenne, F., & Bertagna, X. (1998). Overexpression of vasopressin (V3) and corticotrophin‐releasing hormone receptor genes in corticotroph tumours. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1998.00560.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.